🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic cancer.

“The brilliant light of our household has faded away for us in this life,” his family confirmed. “After a lengthy and courageous struggle with cancer, we are heartbroken to announce that D’Angelo, known to his followers around the world as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his innovative neo-soul sound and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to instant praise. The record achieved No. 4 on the R&B charts, earned platinum status later that year, and received multiple award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The record debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the artist, famously stripped down to his waist, singing straight into the camera.

D’Angelo stepped back from the spotlight after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a serious car crash that put him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with a further top chart entry on the soul music rankings and a award for Top R&B Record.

Once more, in his own enigmatic fashion, D’Angelo had limited public outings in the following years.

The singer was announced as a headliner for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s health in the weeks before his death, he had apparently been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the disease, on a gifted artist whose life was cut short.

“We are grieved that he can only leave dear memories with his family, but we are eternally grateful for the heritage of extraordinarily moving songs he has left us,” his kin said.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a small organ that generates insulin and is vital in breaking down food, among additional roles. The position and dimensions of the organ in the body make it more difficult to detect malignancy.

Although pancreatic cancer makes up only approximately three percent of malignancy cases annually in the U.S., it is responsible for 7% of malignancy fatalities.

Almost seventy thousand people will be found to have this condition and roughly 52,000 will succumb to the illness in 2025.

“This malignancy is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have limited and ineffective treatment options, and a narrow opportunity to make a significant difference on the well-being of patients,” said a medical oncologist.

Because pancreatic cancer seldom produces early symptoms, it’s often diagnosed only once the condition is advanced. Even when a patient has indicators they are usually nonspecific and may be mistaken for a number of everyday ailments.

“Currently, there is no good way to detect this malignancy in the early stages, except for listening to your body and speaking with your physician if there are unfamiliar signs,” explained a medical director.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an exception, as this malignancy is most common in individuals in the sixty-five to seventy-five age bracket. However, numerous malignancies, such as pancreatic cancer, have become more common in younger people.

“Pancreatic cancer identified prior to fifty is deemed uncommon, yet concerningly, doctors are beginning to see a growing number of younger individuals affected by this disease,” said a expert.

Genetic Background Affects Cancer Risk

Without effective screening tools for pancreatic cancer, experts emphasized the significance of understanding your relatives’ health background. Some contributing elements, such as tobacco use and obesity also play a role in the development of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the U.S. and are more prone to be found to have inoperable cancer.

“The initial action toward lowering one’s chance of pancreatic cancer is assessing personal risk factors. Individuals should examine their family history, genetic background, and medical conditions, such as diabetes, chronic pancreatitis, or overweight that may increase their susceptibility,” advised a medical professional.

Inherited genetic elements are linked to as much as 10% of all pancreatic cancer instances. If someone in your household has had this disease, you may want to think about genetic testing.

“For individuals with a family history of this condition or those having high risk DNA changes, screening may involve sophisticated scans such as MRI scans or internal ultrasound to detect early changes in the organ,” he explained.

For those looking to reduce their risk, habit adjustments may make a difference. The most effective step you can take to reduce your susceptibility of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Heavy drinking is linked to pancreas inflammation, a contributing element for this malignancy, so limiting or avoiding drinks may help lower your chance.

Controlling your body mass or losing weight may also aid decrease your susceptibility. People with excess weight are 20% more likely to develop pancreatic cancer. Pancreatic cancer also is more frequent in people with blood sugar issues, and weight loss can also reduce the chance of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is reason for optimism.

“We are making progress with treatments and newer mixed drug treatments. There are emerging precision medicines that already are making an impact,” said a expert.

For many people, however, awareness about this uncommon but {dev